|
PPT2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.026700E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.767800E-01 |
| Normal-vs-Stage2 |
7.299000E-03 |
| Normal-vs-Stage3 |
6.4966000024036E-08 |
| Normal-vs-Stage4 |
8.56470000476506E-08 |
| Stage1-vs-Stage2 |
1.030290E-02 |
| Stage1-vs-Stage3 |
3.84319998047999E-09 |
| Stage1-vs-Stage4 |
7.73689999844507E-08 |
| Stage2-vs-Stage3 |
2.525000E-01 |
| Stage2-vs-Stage4 |
1.026390E-01 |
| Stage3-vs-Stage4 |
4.572000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.88359999999865E-05 |
| Normal-vs-AfricanAmerican |
4.358400E-01 |
| Normal-vs-Asian |
8.192000E-01 |
| Caucasian-vs-AfricanAmerican |
2.203300E-03 |
| Caucasian-vs-Asian |
1.077020E-01 |
| AfricanAmerican-vs-Asian |
9.213600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.031850E-04 |
| Normal-vs-Female |
3.430100E-02 |
| Male-vs-Female |
4.640000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.277810E-01 |
| Normal-vs-Age(41-60Yrs) |
8.181900E-03 |
| Normal-vs-Age(61-80Yrs) |
2.646300E-04 |
| Normal-vs-Age(81-100Yrs) |
8.064100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.144400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.692200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.452200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.188400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.287800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.932800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.375700E-03 |
| Normal-vs-Grade 2 |
3.500000E-01 |
| Normal-vs-Grade 3 |
1.85117000000012E-05 |
| Normal-vs-Grade 4 |
5.14509990168222E-10 |
| Grade 1-vs-Grade 2 |
8.122400E-03 |
| Grade 1-vs-Grade 3 |
1.43040000000205E-06 |
| Grade 1-vs-Grade 4 |
3.20759999672404E-08 |
| Grade 2-vs-Grade 3 |
1.70461999999816E-05 |
| Grade 2-vs-Grade 4 |
3.21789994650601E-09 |
| Grade 3-vs-Grade 4 |
9.424000E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.263000E-01 |
| Normal-vs-ccB subtype |
2.31839999975669E-07 |
| ccA subtype-vs-ccB subtype |
3.35850000032778E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.201900E-04 |
| Normal-vs-N1 |
6.31159999999742E-05 |
| N0-vs-N1 |
3.245800E-02 |
|
|
